Revance Therapeutics Inc. (RVNC)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Graham Capital ManagementNOTE 1.750% 2/1

Kenneth Tropin

36,429,000 $31,585,156 0.54%
2.
Alpine Associates

Robert Emil Zoellner

4,162,861 $21,605,249 0.99%
3.
D E ShawNOTE 1.750% 2/1

D. E. Shaw

17,230,000 $14,706,215 -58% 0.01%
4.
Magnetar Capital

Alec Litowitz And Ross Laser

2,500,171 $12,975,887 0.28%
5. 2,500,000 $12,975,000 +525% 0.92%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.98 30,000 Officer, Director 1,015,468 2024-03-06 Filing
$15.74 6,400 Director 26,913 2021-12-13 Filing
$14.43 30,000 Officer, Director 95,463 2021-12-03 Filing
$12.90 40,000 Officer, Director 110,913 2021-11-29 Filing
$31.20 900 Director 6,150 2018-03-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.80 2,392 Officer 114,864 2024-04-16 Filing
$5.04 9,211 Officer 167,550 2024-03-18 Filing
$5.04 8,125 Officer 137,815 2024-03-18 Filing
$5.04 9,361 Officer 192,666 2024-03-18 Filing
$17.06 11,000 Officer 44,066 2023-09-06 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 11,939,076 $104,944,478 0.01%
2. 7,453,371 $65,515,131 0%
3. 5,069,625 $44,562,004 0%
4. 4,749,539 $41,748,450 0.01%
5. 4,643,419 $40,815,652 0%
News See All